Big Lots Inc. (NYSE: BIG) beat earnings estimates for the second quarter of 2019 while revenues were in line with forecasts. The consensus estimate was for earnings of $0.40 per share on revenue of $1.25 billion. Shares were up 10% in premarket hours on Friday.
Net sales of $1.25 billion was up 2.5% from the same period last year. The growth was driven by positive comparable store sales and sales growth in high volume new stores. Comparable store sales increased 1.2%.
GAAP net income was $6.2 million, or $0.16 per share, compared to $24.2 million, or $0.59 per share last year. The results include after-tax charges of $14.5 million, or $0.37 per share, related to the implementation of the company’s strategic business transformation. Adjusted net income was $20.6 million, or $0.53 per share.
Bruce Thorn, President and CEO said, “We are pleased with our performance for the second quarter, which was in line with our sales guidance and ahead on earnings. Going forward, despite the current tariff headwinds, we are confident we will be able to navigate through this environment to deliver a good outcome for 2019.”
Inventory increased 2% year-over-year to $874 million as a result of moving forward inventory commitments to support assortment resets in the Furniture and Soft Home categories, and slower sell-through of seasonally sensitive products due to weather.
For the third quarter of 2019, the company expects adjusted loss of $0.15-0.25 per share. Comparable store sales are expected to remain approx. flat. For fiscal year 2019, adjusted EPS is expected to be $3.70-3.85. Comparable store sales is expected to be flat to slightly positive.
Big Lots ended the second quarter with $54 million of cash and cash equivalents and $468 million of borrowings under its credit facility.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on